Poster Session I - RECOVERY, REHABILITATION AND OUTCOME 03.00 - RECOVERY, REHABILITATION AND OUTCOME - 03.03 - PROGNOSIS AND OUTCOME AFTER STROKE P227 - ESOC25-178 HEALTH RELATED QUALITY (EQ-5D-3L) AMONG PATIENTS WITH DIFFERENT FUNCTIONAL OUTCOME (GOSE) A YEAR AFTER ANEURYSMAL SUBARACHNOID HAEMORRHAGE IN A SWEDISH NATIONAL COHORT - TARGETING HIDDEN NEEDS Helena Aineskog 1 , Elisabeth Ronne Engstrm 2 , Bryndis Baldvinsdttir 3 , Asgeir Jakola 4 , Ola Nilsson 3 , Mikael Svensson 5 , Peter Alpkvist 5 , Jan Hillman 6 , Peter Lindvall 1 1 Department of Clinical Sciences - Neurosciences, Ume University, Ume, Sweden, 2 Department of Medical Sciences - Neurosurgery, Uppsala, Sweden, 3 Department of Clinical Sciences - Neurosurgery, Lund, Sweden, 4 Department of Clinical Neuroscience, University of Gothenburg, Gothenburg, Sweden, 5 Department of Clinical Neuroscience, Karolinska Institute, Stockholm, Sweden, 6 Department of Clinical Sciences, Linkping University, Linkoping, Sweden Background and Aims: Aneurysmal subarachnoid hemorrhage (aSAH) is a devastating condition and improving health related quality of life (HRQoL), a central goal
Regulatory status and legality 2
Bruising is possible, but very rare in our experience, and usually limited to patients who are on blood-thinning agents or who are particularly proned to bruising
During Checkout Peptide vendors that push dosing guidance, frame compounds as treatments, or make outcome-based claims are operating outside research-use-only boundaries, putting you in a compliance grey zone alongside them
At the same time, more of your existing NAD+ gets consumed by enzymes like CD38 and PARPs, which are activated by things like inflammation, oxidative stress, and DNA damage
